GIPR and type 2 diabetes mellitus: A missense variant in the GIPR, E354Q—whereby a glutamine (Q) at amino acid position 354 replaces a glutamic acid (E), identified in a genome-wide association study (GWAS), is linked with increased risk of T2D and higher BMI (Speliotes et al., 2010).